ArticleClinical pharmacology and therapeutics2026
Enzalutamide-Induced Host Metabolic Reprogramming Is Associated with Treatment Outcomes in Patients with Castration-Resistant Prostate Cancer: A Hypothesis-Generating Study.
Giuseppe Corona et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.